BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28941330)

  • 1. Purity of islet preparations and 5-year metabolic outcome of allogenic islet transplantation.
    Benomar K; Chetboun M; Espiard S; Jannin A; Le Mapihan K; Gmyr V; Caiazzo R; Torres F; Raverdy V; Bonner C; D'Herbomez M; Pigny P; Noel C; Kerr-Conte J; Pattou F; Vantyghem MC
    Am J Transplant; 2018 Apr; 18(4):945-951. PubMed ID: 28941330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus.
    Warnock GL; Meloche RM; Thompson D; Shapiro RJ; Fung M; Ao Z; Ho S; He Z; Dai LJ; Young L; Blackburn L; Kozak S; Kim PT; Al-Adra D; Johnson JD; Liao YH; Elliott T; Verchere CB
    Arch Surg; 2005 Aug; 140(8):735-44. PubMed ID: 16103282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential benefit of non-purified islets preparations for islet transplantation.
    Webb MA; Dennison AR; James RF
    Biotechnol Genet Eng Rev; 2012; 28():101-14. PubMed ID: 22616483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rescue purification maximizes the use of human islet preparations for transplantation.
    Ichii H; Pileggi A; Molano RD; Baidal DA; Khan A; Kuroda Y; Inverardi L; Goss JA; Alejandro R; Ricordi C
    Am J Transplant; 2005 Jan; 5(1):21-30. PubMed ID: 15636608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the number of infusions on 2-year results of islet-after-kidney transplantation in the GRAGIL network.
    Borot S; Niclauss N; Wojtusciszyn A; Brault C; Demuylder-Mischler S; Müller Y; Giovannoni L; Parnaud G; Meier R; Badet L; Bayle F; Frimat L; Kessler L; Morelon E; Penfornis A; Thivolet C; Toso C; Morel P; Bosco D; Colin C; Benhamou PY; Berney T;
    Transplantation; 2011 Nov; 92(9):1031-8. PubMed ID: 21926944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of transplantation site and islet mass on long-term survival and metabolic and hormonal function of canine purified islet autografts.
    Scharp DW; Marchetti P; Swanson C; Newton M; McCullough CS; Olack B
    Cell Transplant; 1992; 1(2-3):245-54. PubMed ID: 1344296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term function (6 years) of islet allografts in type 1 diabetes.
    Alejandro R; Lehmann R; Ricordi C; Kenyon NS; Angelico MC; Burke G; Esquenazi V; Nery J; Betancourt AE; Kong SS; Miller J; Mintz DH
    Diabetes; 1997 Dec; 46(12):1983-9. PubMed ID: 9392484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary graft function, metabolic control, and graft survival after islet transplantation.
    Vantyghem MC; Kerr-Conte J; Arnalsteen L; Sergent G; Defrance F; Gmyr V; Declerck N; Raverdy V; Vandewalle B; Pigny P; Noel C; Pattou F
    Diabetes Care; 2009 Aug; 32(8):1473-8. PubMed ID: 19638525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten-Year Outcome of Islet Alone or Islet After Kidney Transplantation in Type 1 Diabetes: A Prospective Parallel-Arm Cohort Study.
    Vantyghem MC; Chetboun M; Gmyr V; Jannin A; Espiard S; Le Mapihan K; Raverdy V; Delalleau N; Machuron F; Hubert T; Frimat M; Van Belle E; Hazzan M; Pigny P; Noel C; Caiazzo R; Kerr-Conte J; Pattou F;
    Diabetes Care; 2019 Nov; 42(11):2042-2049. PubMed ID: 31615852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous glucose monitoring after islet transplantation in type 1 diabetes: an excellent graft function (β-score greater than 7) Is required to abrogate hyperglycemia, whereas a minimal function is necessary to suppress severe hypoglycemia (β-score greater than 3).
    Vantyghem MC; Raverdy V; Balavoine AS; Defrance F; Caiazzo R; Arnalsteen L; Gmyr V; Hazzan M; Noël C; Kerr-Conte J; Pattou F
    J Clin Endocrinol Metab; 2012 Nov; 97(11):E2078-83. PubMed ID: 22996144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Isogenic islet transplantation on the rat liver (method for isolation and purification of the Langerhans islets)].
    Chaib E; Papalois A; Brons IG; Calne RY
    Arq Gastroenterol; 2000; 37(1):44-51. PubMed ID: 10962628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous islet-kidney vs pancreas-kidney transplantation in type 1 diabetes mellitus: a 5 year single centre follow-up.
    Gerber PA; Pavlicek V; Demartines N; Zuellig R; Pfammatter T; Wüthrich R; Weber M; Spinas GA; Lehmann R
    Diabetologia; 2008 Jan; 51(1):110-9. PubMed ID: 17973096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Allogenic islet transplantation on the rat liver after allogenic nonparenchymal cells injection in the thymus].
    Chaib E; Papalois A; Brons IG; Calne RY
    Arq Gastroenterol; 2006; 43(4):321-7. PubMed ID: 17406763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-Year Metabolic, Functional, and Safety Results of Patients With Type 1 Diabetes Transplanted With Allogenic Islets Within the Swiss-French GRAGIL Network.
    Lablanche S; Borot S; Wojtusciszyn A; Bayle F; Tétaz R; Badet L; Thivolet C; Morelon E; Frimat L; Penfornis A; Kessler L; Brault C; Colin C; Tauveron I; Bosco D; Berney T; Benhamou PY;
    Diabetes Care; 2015 Sep; 38(9):1714-22. PubMed ID: 26068866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center.
    Goss JA; Schock AP; Brunicardi FC; Goodpastor SE; Garber AJ; Soltes G; Barth M; Froud T; Alejandro R; Ricordi C
    Transplantation; 2002 Dec; 74(12):1761-6. PubMed ID: 12499894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of current product release criteria for identification of human islet preparations suitable for clinical transplantation.
    Eckhard M; Brandhorst D; Winter D; Jaeger C; Jahr H; Bretzel RG; Brendel MD
    Transplant Proc; 2004 Jun; 36(5):1528-31. PubMed ID: 15251377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attainment of metabolic goals in the integrated UK islet transplant program with locally isolated and transported preparations.
    Brooks AM; Walker N; Aldibbiat A; Hughes S; Jones G; de Havilland J; Choudhary P; Huang GC; Parrott N; McGowan NW; Casey J; Mumford L; Barker P; Burling K; Hovorka R; Walker M; Smith RM; Forbes S; Rutter MK; Amiel S; Rosenthal MJ; Johnson P; Shaw JA
    Am J Transplant; 2013 Dec; 13(12):3236-43. PubMed ID: 24119216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymes for Pancreatic Islet Isolation Impact Chemokine-Production and Polarization of Insulin-Producing β-Cells with Reduced Functional Survival of Immunoisolated Rat Islet-Allografts as a Consequence.
    de Vos P; Smink AM; Paredes G; Lakey JR; Kuipers J; Giepmans BN; de Haan BJ; Faas MM
    PLoS One; 2016; 11(1):e0147992. PubMed ID: 26824526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Islet alone versus islet after kidney transplantation: metabolic outcomes and islet graft survival.
    Deng S; Markmann JF; Rickels M; Yeh H; Kim JI; Lian MM; Gu Y; Markmann E; Palanjian M; Barker CF; Naji A
    Transplantation; 2009 Sep; 88(6):820-5. PubMed ID: 19920782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved outcomes of islet autotransplant after total pancreatectomy by combined blockade of IL-1β and TNFα.
    Naziruddin B; Kanak MA; Chang CA; Takita M; Lawrence MC; Dennison AR; Onaca N; Levy MF
    Am J Transplant; 2018 Sep; 18(9):2322-2329. PubMed ID: 29862647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.